Top Markets
#1 Siren Siren +38.43%
#2 RedStone RedStone +23.87%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#4 Ocean Protocol Ocean Protocol +15.39%
#5 Cysic Cysic +14.92%
#6 Arowana Arowana +13.88%
#7 Verus Coin Verus Coin +13.51%
#8 Perle Perle +11.75%
#9 KUB Coin KUB Coin +11.63%
#10 Wiki Cat Wiki Cat +10.25%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Pozycja w akcjach #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Cena akcji
$1.49
Ostatnia synchronizacja: 2026-08-17
Kapitalizacja rynkowa
$10.94M
Zmiana (1 dzień)
4.58%
Zmiana (1 rok)
-55.67%
Kraj
US
Handel Ainos, Inc. (AIMD)

Kategoria

Healthcare
Zyski dla Ainos, Inc. (AIMD)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Ainos, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Ainos, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR